Exelixis, Inc. (EXEL)

44.57 +0.51 (+1.16%) USD  |  NASDAQ  |  Jan 13, 10:56
More

Exelixis Other Current Liability (Quarterly)

Other Current Liability (Quarterly) Chart

View Other Current Liability (Quarterly) for EXEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Current Liability (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Current Liability (Quarterly) Range, Past 5 Years

View Other Current Liability (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Current Liability (Quarterly) Benchmarks

View Other Current Liability (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. --
ADMA Biologics, Inc. Upgrade
Aldeyra Therapeutics, Inc. --
Natera, Inc. --
Merck & Co., Inc. --